Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (91-100 of 334) with videos related to

Pageof 34
Sort By:
Immunologic Research|July 1, 2011
Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunitySteve C Lee, Raghvendra M Srivastava, Andrés López-Albaitero, et al.
Journal of Translational Medicine|June 27, 2007
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft modelEzogelin Oflazoglu, Mark Elliott, Hiroshi Takita, et al.
Journal of the National Cancer Institute|September 16, 2009
Polyclonality of BRAF mutations in acquired melanocytic neviJingrong Lin, Minoru Takata, Hiroshi Murata, et al.
Scientific Reports|August 31, 2017
ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsXuedong Wang, Yueping Wang, Juan Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulationBarbara Seliger, Derek Atkins, Michaela Bock, et al.
Immunology|January 16, 2008
Differential contribution of TAP and tapasin to HLA class I antigen expressionAlan Belicha-Villanueva, Sarah McEvoy, Kelly Cycon, et al.
Seminars in Oncology|December 3, 2014
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumorsFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Oncotarget|January 27, 2018
Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAPXuedong Wang, Xinguo Wang, Juan Gu, et al.
Frontiers in Veterinary Science|February 28, 2022
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational ResearchLidia Tarone, Davide Giacobino, Mariateresa Camerino, et al.
Critical Reviews in Immunology|December 14, 2004
Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significanceMichael R Campoli, Chien-Chung Chang, Toshiro Kageshita, et al.
Pageof 34

Showing results (91-100 of 334) with videos related to

Sort By:
Pageof 34
Immunologic Research|July 1, 2011
Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunitySteve C Lee, Raghvendra M Srivastava, Andrés López-Albaitero, et al.
Journal of Translational Medicine|June 27, 2007
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft modelEzogelin Oflazoglu, Mark Elliott, Hiroshi Takita, et al.
Journal of the National Cancer Institute|September 16, 2009
Polyclonality of BRAF mutations in acquired melanocytic neviJingrong Lin, Minoru Takata, Hiroshi Murata, et al.
Scientific Reports|August 31, 2017
ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsXuedong Wang, Yueping Wang, Juan Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulationBarbara Seliger, Derek Atkins, Michaela Bock, et al.
Immunology|January 16, 2008
Differential contribution of TAP and tapasin to HLA class I antigen expressionAlan Belicha-Villanueva, Sarah McEvoy, Kelly Cycon, et al.
Seminars in Oncology|December 3, 2014
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumorsFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Oncotarget|January 27, 2018
Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAPXuedong Wang, Xinguo Wang, Juan Gu, et al.
Frontiers in Veterinary Science|February 28, 2022
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational ResearchLidia Tarone, Davide Giacobino, Mariateresa Camerino, et al.
Critical Reviews in Immunology|December 14, 2004
Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significanceMichael R Campoli, Chien-Chung Chang, Toshiro Kageshita, et al.
Pageof 34